2024

BindingDB Entry 50018763: Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors.

BindingDB

Description

No description available.

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.3

FAIR Score

52%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

BindingDB

License

Attribution 3.0 United States

Assigned Domain

Subfield

Molecular Biology

Field

Biochemistry, Genetics and Molecular Biology

Domain

Life Sciences

Confidence Score

62%

Source

Scholar Data Model

Keywords

BDNF/NT-3 growth factors receptor, High affinity nerve growth factor receptor, Interleukin-1 receptor-associated kinase 1, Interleukin-1 receptor-associated kinase 4, NT-3 growth factor receptor, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, Receptor-type tyrosine-protein kinase FLT3, and Tyrosine-protein kinase BTK, Astrazeneca, Affinity

Normalization Factors

FT

53.85

CTw

1.00

MTw

1.00